药物对比
Galcanezumab vs Zavegepant
比较 Galcanezumab（Emgality，用于偏头痛预防的注射剂）与 Zavegepant（Zavzpret，用于急性治疗的鼻喷雾剂）。两者均靶向 CGRP 通路。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when evaluating CGRP-targeted options for patients needing either long-term migraine prevention or fast-acting acute therapy.
结论
These medications are not directly comparable as one is preventive and the other is for acute use, making the better choice patient-specific.
全部药物对比